au.\*:("WHITEHOUSE, Peter J")
Results 1 to 25 of 57
Selection :
Antiaging medicine and mild cognitive impairment : Practice and policy issues for geriatricsWHITEHOUSE, Peter J; JUENGST, Eric T.Journal of the American Geriatrics Society. 2005, Vol 53, Num 8, pp 1417-1422, issn 0002-8614, 6 p.Article
Quality of life in dementia : State of the art: Report of the international working group for harmonization of dementia drug guidelines and the Alzheimer's Society Satellite MeetingMACK, James L; WHITEHOUSE, Peter J.Alzheimer disease and associated disorders. 2001, Vol 15, Num 2, pp 69-71, issn 0893-0341Article
Defining and measuring outcomes in Alzheimer disease researchWHITEHOUSE, Peter J; MASLOW, Katie; SMYTH, Kathleen et al.Alzheimer disease and associated disorders. 1997, Vol 11, issn 0893-0341, 203 p., SUP6Conference Proceedings
Research advances in the neurology of dementiaWHITEHOUSE, Peter J.Alzheimer disease and associated disorders. 2003, Vol 17, Num 2, pp 127-128, issn 0893-0341, 2 p.Article
Assessing quality of life in Alzheimer disease researchLAWTON, M. P.Alzheimer disease and associated disorders. 1997, Vol 11, pp 91-99, issn 0893-0341, SUP6Conference Paper
Service use and cost outcomes for persons with Alzheimer diseaseFOX, P. J.Alzheimer disease and associated disorders. 1997, Vol 11, pp 125-134, issn 0893-0341, SUP6Conference Paper
Which outcomes matter in Alzheimer disease and who should define them?KANE, R. L.Alzheimer disease and associated disorders. 1997, Vol 11, pp 12-17, issn 0893-0341, SUP6Conference Paper
Measuring functioning in daily activities for persons with dementiaSPECTOR, W. D.Alzheimer disease and associated disorders. 1997, Vol 11, pp 81-90, issn 0893-0341, SUP6Conference Paper
Minority issues in Alzheimer disease outcomes researchHAZUDA, H. P.Alzheimer disease and associated disorders. 1997, Vol 11, pp 156-161, issn 0893-0341, SUP6Conference Paper
Use of proxies to measure health and functional outcomes in effectiveness research in persons with Alzheimer disease and related disordersMAGAZINER, J.Alzheimer disease and associated disorders. 1997, Vol 11, pp 168-174, issn 0893-0341, SUP6Conference Paper
Assessing physical status in Alzheimer disease researchWARSHAW, G.Alzheimer disease and associated disorders. 1997, Vol 11, pp 66-72, issn 0893-0341, SUP6Conference Paper
Utility of the Judgment Questionnaire Subtest of the Neurobehavioral Cognitive Status Examination in the evaluation of individuals with Alzheimer's diseaseWOODS, Denise C; PATTERSON, Marian B; WHITEHOUSE, Peter J et al.Clinical gerontologist. 2000, Vol 21, Num 4, pp 49-66, issn 0731-7115Article
The perspective of the person with Alzheimer disease : Which outcomes matter in early to middle stages of dementia?GWYTHER, L. P.Alzheimer disease and associated disorders. 1997, Vol 11, pp 18-24, issn 0893-0341, SUP6Conference Paper
Variable Judgments of Decisional Capacity in Cognitively Impaired Research SubjectsSTOCKING, Carol B; HOUGHAM, Gavin W; DANNER, Deborah D et al.Journal of the American Geriatrics Society. 2008, Vol 56, Num 10, pp 1893-1897, issn 0002-8614, 5 p.Article
Quality-of-life assessment in dementia drug development : Position paper from the international working group on harmonization of dementia drug guidelinesWHITEHOUSE, P. J; ORGOGOZO, J.-M; DAL-BIANCO, P et al.Alzheimer disease and associated disorders. 1997, Vol 11, pp 56-60, issn 0893-0341, SUP3Article
Assessing family and staff caregiver outcomes in Alzheimer disease researchBUCKWALTER, K. C; MAAS, M; REED, D et al.Alzheimer disease and associated disorders. 1997, Vol 11, pp 105-116, issn 0893-0341, SUP6Conference Paper
Defining and measuring outcomes in end-stage dementiaTENO, J. M; LANDRUM, K; LYNN, J et al.Alzheimer disease and associated disorders. 1997, Vol 11, pp 25-29, issn 0893-0341, SUP6Conference Paper
Objective psychometric tests in clinical trials of dementia drugs : Position paper from the international working group on harmonization of dementia drug guidelinesFERRIS, S. H; LUCCA, U; MOHS, R et al.Alzheimer disease and associated disorders. 1997, Vol 11, pp 34-38, issn 0893-0341, SUP3Article
Clinical global measures of dementia : Position paper from the international working group on harmonization of dementia drug guidelinesREISBERG, B; SCHNEIDER, L; MORRIS, J. C et al.Alzheimer disease and associated disorders. 1997, Vol 11, pp 8-18, issn 0893-0341, SUP3Article
Economic research on Alzheimer disease : A review of the literatureERNST, R. L; HAY, J. W.Alzheimer disease and associated disorders. 1997, Vol 11, pp 135-145, issn 0893-0341, SUP6Conference Paper
Methodological issues in cognitive assessment and their impact on outcome measurementTERESI, J. A; HOLMES, D.Alzheimer disease and associated disorders. 1997, Vol 11, pp 146-155, issn 0893-0341, SUP6Conference Paper
The measurement of caregiver outcomes in Alzheimer disease researchSCHULZ, R; WILLIAMSON, G. M.Alzheimer disease and associated disorders. 1997, Vol 11, pp 117-124, issn 0893-0341, SUP6Conference Paper
The potential for using administrative and clinical data to analyze outcomes for the cognitively impaired : An assessment of the minimum data set for nursing homesPHILLIPS, C. D; MORRIS, J. N.Alzheimer disease and associated disorders. 1997, Vol 11, pp 162-167, issn 0893-0341, SUP6Conference Paper
Disclosure of APOE Genotype for Risk of Alzheimer's DiseaseGREEN, Robert C; ROBERTS, J. Scott; CHEN, Clara et al.The New England journal of medicine. 2009, Vol 361, Num 3, pp 245-254, issn 0028-4793, 10 p.Article
Dementia, Diagnostic Disclosure, and Self-Reported Health StatusCAMPBELL, Kellie H; STOCKING, Carol B; HOUGHAM, Gavin W et al.Journal of the American Geriatrics Society. 2008, Vol 56, Num 2, pp 296-300, issn 0002-8614, 5 p.Article